Dr. Gildas Deniau, PhD

Principal Scientist, Chemical Process R&D at Johnson & Johnson Innovative Medicine

Speaker

Gildas Deniau is a Principal Scientist at Johnson&Johnson in Schaffhausen since 2019 and has over 15 years of experience in the peptide pharmaceutical industry (biotech, CDMO and pharma compagnies). As team and project leader, he has directed cross-disciplinary teams through the full peptide technical development lifecycle – from discovery (parallel syntheses, SAR), to process development SPPS/LPPS, (leading & monitoring internal/external R&D and manufacturing) and large scale GMP manufacturing SPPS/LPPS (Planning, compliance, troubleshooting). His current expertise is focused on developing peptides from pre-clinical to Phase 3.

Gildas holds a PhD in medicinal organic chemistry from St Andrews (Scotland) and completed a postdoc in peptide chemistry at ETH Zürich (Switzerland).